Gender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior

Pharmacological Reports

Volumn 65, Issue 6, 2013, Pages 1580-1590

  Kreiner, Grzegorz ^a   Chmielarz, Piotr ^a   Roman, Adam ^a   Nalepa, Irena ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; Depression; Forced swim test; Gender; Genetic models; Knockout; Mice; Tail suspension test

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; MAPROTILINE; PHEROMONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL EFFECTIVENESS; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ESTRUS CYCLE; EXPERIMENTAL BEHAVIORAL TEST; GENETIC MODEL; HUMAN; NONHUMAN; PHENOTYPE; REPRODUCIBILITY; REVIEW; SEX DIFFERENCE; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; MICE; SEX FACTORS;

EID: 84894213896     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71519-6     Document Type: Article

References (88)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM: Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry, 2008, 63, 642-649. (Pubitemid 351329281)
2. Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP, HamonM, Adrien J: Early life blockade of 5-hydroxytryptamine 1Areceptors normalizes sleep and depressionlike behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci, 2006, 26, 5554-5564. (Pubitemid 44318406)
3. Alonso SJ, Castellano MA, Afonso D, Rodriguez M: Sex differences in behavioral despair: Relationships between behavioral despair and open field activity. Physiol Behav, 1991, 49, 69-72.
4. Aonurm-Helm A, Jurgenson M, Zharkovsky T, Sonn K, Berezin V, Bock E, Zharkovsky A: Depression-like be-haviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL. Eur J Neurosci, 2008, 28, 1618-1628.
5. Baca E, Garcia-Garcia M, Porras-Chavarino A: Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28, 57-65. (Pubitemid 37548498)
6. Bagdy G: Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences. Ann N Y Acad Sci, 1998, 851, 357-363.
7. Bale TL, Vale WW: Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: Sexually dichotomous responses. J Neurosci, 2003, 23, 5295-5301. (Pubitemid 36793258)
8. Barros HM, Ferigolo M: Ethopharmacology of imipramine in the forced-swimming test: Gender differences. Neurosci Biobehav Rev, 1998, 23, 279-286. (Pubitemid 29011630)
9. Bergner CL, Smolinsky AN, Hart PC, Dufour BD, Egan RJ, Laporte JL, Kalueff AV: Mouse models for studying depression-like states and antidepressant drugs. Methods Mol Biol, 2010, 602, 267-282.
10. Bhatnagar S, Nowak N, Babich L, Bok L: Deletion of the 5-HT3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests. Behav Brain Res, 2004, 153, 527-535. (Pubitemid 38953130)
11. Boyce-Rustay JM, Holmes A: Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic-and antidepressant-like effects in mice. Neuropsychopharmacology, 2006, 31, 2405-2414. (Pubitemid 44607058)
12. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Müller U et al.: Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science, 1995, 268, 1763-1766.
13. Champlin AK: Suppression of oestrus in grouped mice: The effects of various densities and the possible nature of the stimulus. J Reprod Fertil, 1971, 27, 233-241.
14. Chen A, Zorrilla E, Smith S, Rousso D, Levy C, Vaughan J, Donaldson C et al.: Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J Neurosci, 2006, 26, 5500-5510. (Pubitemid 44318402)
15. Chmielarz P, Kusmierczyk J, Parlato R, Schutz G, Nalepa I, Kreiner G: Inactivation of glucocorticoid receptor in noradrenergic system influences anxiety-and depressivelike behavior in mice. PLoS One, 2013, 8, e72632.
16. Crawley JN, Paylor R: A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav, 1997, 31, 197-211. (Pubitemid 27305718)
17. Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H: Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci, 2003, 17, 2409-2417. (Pubitemid 36793749)
18. Cryan JF, Mombereau C: In search of a depressed mouse: Utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry, 2004, 9, 326-357. (Pubitemid 38534696)
19. D'Incau P, Lapeyre-Mestre M, Carvajal A, Donati M, Salado I, Rodriguez L, Sainz M et al.: No differences between men and women in adverse drug reactions related to psychotropic drugs: A survey from France, Italy and Spain. Fundam Clin Pharmacol, 2013, doi: 10.1111/fcp.12032. [Epub ahead of print].
20. Dalal SJ, Estep JS, Valentin-Bon IE, Jerse AE: Standardization of the Whitten Effect to induce susceptibility to Neisseria gonorrhoeae in female mice. Contemp Top Lab Anim Sci, 2001, 40, 13-17. (Pubitemid 33673416)
21. Dalla C, Antoniou K, Papadopoulou-Daifoti Z, Balthazart J, Bakker J: Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology. Eur J Neurosci, 2004, 20, 217-228. (Pubitemid 38932142)
22. Diaz-Ruiz C, Parlato R, Aguado F, Urena JM, Burgaya F, Martinez A, Carmona MA et al.: Regulation of neural migration by the CREB/CREM transcription factors and altered Dab1 levels in CREB/CREM mutants. Mol Cell Neurosci, 2008, 39, 519-528.
23. Doze VA, Handel EM, Jensen KA, Darsie B, Luger EJ, Haselton JR, Talbot JN, Rorabaugh BR: A1A-and a1B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res, 2009, 1285, 148-157.
24. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry, 1997, 54, 597-606. (Pubitemid 27306570)
25. Dziedzicka-Wasylewska M, Faron-Górecka A, Kuoemider M, Drozdowska E, Rogó Z, Siwanowicz J, Caron MG, Bönisch H: Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology, 2006, 31, 2424-2432. (Pubitemid 44607060)
26. El Yacoubi M, Ledent C, Parmentier M, Bertorelli R, Ongini E, Costentin J, Vaugeois JM: Adenosine A2A receptor antagonists are potential antidepressants: Evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol, 2001, 134, 68-77. (Pubitemid 32835469)
27. Fedorova IM, Jacobson MA, Basile A, Jacobson KA: Behavioral characterization of mice lacking the A3 adenosine receptor: Sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol, 2003, 23, 431-447. (Pubitemid 36676284)
28. Fell MJ, Witkin JM, Falcone JF, Katner JS, Perry KW, Hart J, Rorick-Kehn L et al.: N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl) benzyl)-1-methy l-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: In vivo profiling suggests a link between behavioral and central nervous system neurochemical changes. J Pharmacol Exp Ther, 2011, 336, 165-177.
29. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K et al.: Mice deficient for delta-and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet, 2000, 25, 195-200. (Pubitemid 30394992)
30. Frazer A, Morilak DA: What should animal models of depression model? Neurosci Biobehav Rev, 2005, 29, 515-523. (Pubitemid 40762597)
31. Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ et al.: The history and current state of antidepressant clinical trial design: A call to action for proof-of-concept studies. J Clin Psychiatry, 2008, 69, 1513-1528.
32. Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F et al.: Increased stress response and beta-phenylethylamine in MAOB-deficient mice. Nat Genet, 1997, 17, 206-210.
33. Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA, Bromidge F et al.: Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology, 2005, 48, 492-502. (Pubitemid 40332407)
34. Haller J, Bakos N, Rodriguiz RM, CaronMG,WetselWC, Liposits Z: Behavioral responses to social stress in noradrenaline transporter knockout mice: Effects on social behavior and depression. Brain Res Bull, 2002, 58, 279-284. (Pubitemid 34786459)
35. Hashimoto H, Hashimoto R, Shintani N, Tanaka K, Yamamoto A, Hatanaka M, Guo X et al.: Depression-like behavior in the forced swimming test in PACAPdeficient mice: Amelioration by the atypical antipsychotic risperidone. J Neurochem, 2009, 110, 595-602.
36. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH: Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA, 1998, 95, 15049-15054. (Pubitemid 29003754)
37. Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P: Are gender differences important for the clinical effects of antidepressants? Am J Psychiatry, 2003, 160, 1643-1650. (Pubitemid 41079551)
38. Hill TD, Needham BL: Rethinking gender and mental health: A critical analysis of three propositions. Soc Sci Med, 2013, 92, 83-91.
39. Holden C: Sex and the suffering brain. Science, 2005, 308, 1574.
40. Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR, Crawley JN: Behavioral characterization of dopamine D-sub-5 receptor null mutant mice. Behav Neurosci, 2001, 115, 1129-1144. (Pubitemid 32906651)
41. Holmes A, Yang RJ, Murphy DL, Crawley JN: Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology, 2002, 27, 914-923. (Pubitemid 35447628)
42. Inta D, Vogt MA, Luoni A, Filipoviæ D, Lima-Ojeda JM, Pfeiffer N, Gasparini F et al.: Significant increase in anxiety during aging in mGlu5 receptor knockout mice. Behav Brain Res, 2013, 241, 27-31.
43. Jones MD, Lucki I: Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology, 2005, 30, 1039-1047. (Pubitemid 40720961)
44. Keers R, Aitchison KJ: Gender differences in antidepressant drug response. Int Rev Psychiatry, 2010, 22, 485-500.
45. Klein LC, Corwin EJ: Seeing the unexpected: How sex differences in stress responses may provide a new perspective on the manifestation of psychiatric disorders. Curr Psychiatry Rep, 2002, 4, 441-448.
46. Krishnan V, Graham A, Mazei-Robison MS, Lagace DC, Kim KS, Birnbaum S, Eisch AJ et al.: Calcium-sensitive adenylyl cyclases in depression and anxiety: Behavioral and biochemical consequences of isoform targeting. Biol Psychiatry, 2008, 64, 336-343.
47. Krishnan V, Nestler EJ: The molecular neurobiology of depression. Nature, 2008, 455, 894-902.
48. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, Jiang J, Mei Z, Wang ZG et al.: Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology, 2007, 32, 1531-1539. (Pubitemid 46920158)
49. Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T: Phenotypic analysis of GalR2 knockout mice in anxietyand depression-related behavioral tests. Neuropeptides, 2008, 42, 387-397.
50. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT, Fahnestock M: Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci, 2001, 115, 1145-1153. (Pubitemid 32906652)
51. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F et al.: Disruption of CREB function in brain leads to neurodegeneration. Nat Genet, 2002, 31, 47-54.
52. Martenyi F, Dossenbach M, Mraz K, Metcalfe S: Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: A double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol, 2001, 11, 227-232. (Pubitemid 32618645)
53. Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I: Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice. J Pharmacol Exp Ther, 2001, 298, 1101-1107. (Pubitemid 32761926)
54. Miyamoto Y, Yamada K, Noda Y,Mori H,MishinaM, Nabeshima T: Lower sensitivity to stress and altered monoaminergic neuronal function inmice lacking the NMDAreceptor e4 subunit. J Neurosci, 2002, 22, 2335-2342. (Pubitemid 35386532)
55. Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF: Genetic and pharmacological evidence of a role for GABAB receptors in the modulation of anxiety-and antidepressant-like behavior. Neuropsychopharmacology, 2004, 29, 1050-1062. (Pubitemid 38670043)
56. Mombereau C, Kaupmann K, Gassmann M, Bettler B, van der Putten H, Cryan JF: Altered anxiety and depression-related behaviour in mice lacking GABAB2 receptor subunits. Neuroreport, 2005, 16, 307-310. (Pubitemid 40364596)
57. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ: Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry, 2007, 61, 187-197. (Pubitemid 46072778)
58. Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J et al.: Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci, 2002, 22, 10883-10890. (Pubitemid 36005163)
59. Painsipp E,Wultsch T, EdelsbrunnerME, Tasan RO, Singewald N, Herzog H, Holzer P: Reduced anxiety-like and depression-related behavior in neuropeptide YY4 receptor knockoutmice. Genes Brain Behav, 2008, 7, 532-542. (Pubitemid 351991488)
60. Palanza P: Animal models of anxiety and depression: How are females different? Neurosci Biobehav Rev, 2001, 25, 219-233. (Pubitemid 32506875)
61. Parker G, Brotchie H: Gender differences in depression. Int Rev Psychiatry, 2010, 22, 429-436.
62. Parker G, Parker K, Austin MP, Mitchell P, Brotchie H: Gender differences in response to differing antidepressant drug classes: Two negative studies. Psychol Med, 2003, 33, 1473-1477. (Pubitemid 37483470)
63. Parlato R, Cruz H, Otto C, Murtra P, Parkitna JR, Martin M, Bura SA et al.: Effects of the cell type-specific ablation of the cAMP-responsive transcription factor in noradrenergic neurons on locus coeruleus firing and withdrawal behavior after chronic exposure to morphine. J Neurochem, 2010, 115, 563-573.
64. Pitychoutis PM, Dalla C, Sideris AC, Tsonis PA, Papadopoulou-Daifoti Z: 5-HT1A, 5-HT2A, and 5-HT2C receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: Sex differences exposed. Neuroscience, 2012, 210, 152-167.
65. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ et al.: Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proc Natl Acad Sci USA, 1998, 95, 14476-14481. (Pubitemid 28549392)
66. Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M et al.: Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci, 2005, 25, 6243-6250. (Pubitemid 40923491)
67. Rupniak NM, Carlson EJ, Webb JK, Harrison T, Porsolt RD, Roux S, de Felipe C et al.: Comparison of the phenotype of NK1R-/-mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol, 2001, 12, 497-508. (Pubitemid 33152274)
68. Sagud M, Hotujac L, Mihaljevic-Peles A, Jakovljevic M: Gender differences in depression. Coll Antropol, 2002, 26, 149-157.
69. Sallinen J, Haapalinna A, MacDonald E, Viitamaa T, Lahdesmaki J, Rybnikova E, Pelto-Huikko M et al.: Genetic alteration of the a2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Mol Psychiatry, 1999, 4, 443-452. (Pubitemid 29497732)
70. Sarkisyan G, Roberts AJ, Hedlund PB: The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior. Behav Brain Res, 2010, 209, 99-108.
71. Schramm NL, McDonald MP, Limbird LE: The a2a-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci, 2001, 21, 4875-4882. (Pubitemid 32565645)
72. Simen BB, Duman CH, Simen AA, Duman RS: TNFa signaling in depression and anxiety: Behavioral consequences of individual receptor targeting. Biol Psychiatry, 2006, 59, 775-785.
73. Simpson J, Ryan C, Curley A, Mulcaire J, Kelly JP: Sex differences in baseline and drug-induced behavioural responses in classical behavioural tests. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 37, 227-236.
74. Smith CM, Lawrence AJ, Sutton SW, Gundlach AL: Behavioral phenotyping of mixed background (129S5:B6) relaxin-3 knockout mice. Ann NY Acad Sci, 2009, 1160, 236-241.
75. Solomon MB, Furay AR, Jones K, Packard AE, Packard BA, Wulsin AC, Herman JP: Deletion of forebrain glucocorticoid receptors impairs neuroendocrine stress responses and induces depression-like behavior in males but not females. Neuroscience, 2012, 203, 135-143.
76. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B: Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol, 2000, 11, 279-290. (Pubitemid 30449759)
77. Tanda K, Nishi A,Matsuo N, Nakanishi K, Yamasaki N, Sugimoto T, Toyama K et al.: Abnormal social behavior, hyperactivity, impaired remote spatialmemory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockoutmice.Mol Brain, 2009, 2, 19.
78. Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G: Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience, 2009, 158, 1717-1730.
79. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R et al.: Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet, 1999, 23, 99-103. (Pubitemid 29418797)
80. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, Herzog H, Sperk G: Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci, 2003, 18, 143-148. (Pubitemid 36920855)
81. van GaalenMM, Stenzel-PooreMP, Holsboer F, Steckler T: Effects of transgenic overproduction of CRH on anxietylike behaviour. Eur J Neurosci, 2002, 15, 2007-2015. (Pubitemid 35471889)
82. Vasiliadis HM, Gagne S, Jozwiak N, Preville M: Gender differences in health service use for mental health reasons in community dwelling older adults with suicidal ideation. Int Psychogeriatr, 2013, 25, 374-381.
83. Weil ZM, Hotchkiss AK, Gatien ML, Pieke-Dahl S, Nelson RJ: Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating. Brain Res Bull, 2006, 68, 425-429. (Pubitemid 43177577)
84. Weisstaub NV: Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science, 2006, 313, 536-540. (Pubitemid 44148461)
85. Xing B, Liu P, Jiang W-h, Liu F, Zhang H, Cao G-f, Chen T, Dang YH: Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice. Behav Brain Res, 2013, 243, 261-266.
86. Yonkers KA: Special issues related to the treatment of depression in women. J Clin Psychiatry, 2003, 64, Suppl 18, 8-13.
87. Zeng H, Schimpf BA, Rohde AD, PavlovaMN, Gragerov A, Bergmann JE: Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxietylike behavior.Mol Endocrinol, 2007, 21, 2795-2804. (Pubitemid 350035160)
88. Zörner B, Wolfer DP, Brandis D, Kretz O, Zacher C, Madani R, Grunwald I et al.: Forebrain-specific trkBreceptor knockout mice: Behaviorally more hyperactive than "depressive". Biol Psychiatry, 2003, 54, 972-982. (Pubitemid 37420083)